USANA Health Sciences (USNA) Misses Q2 EPS by 13c; Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.33 -3.63%
Financial Fact:
Earnings from operations: 35.83M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Earnings from operations: 35.83M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.00, $0.13 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $264 million versus the consensus estimate of $268.44 million.
GUIDANCE:
USANA Health Sciences reiterates FY2022 EPS of $3.85-$4.45, versus the consensus of $4.42. USANA Health Sciences sees FY2022 revenue of $1.015-1.065 billion, versus the consensus of $1.06 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arcutis Biotherapeutics, Inc. (ARQT) Misses Q3 EPS by 12c; Offers Guidance
- Miller Industries (MLR) Misses Q3 EPS by 11c, Misses on Revenue; Offers FY26 Revenue Guidance
- ONE Group Hospitality (STKS) Misses Q3 EPS by 55c, Misses on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
